Doxorubicin downregulates cell surface B7-H1 expression and upregulates its nuclear expression in breast cancer cells: role of B7-H1 as an anti-apoptotic molecule
Open Access
- 13 July 2010
- journal article
- Published by Springer Science and Business Media LLC in Breast Cancer Research
- Vol. 12 (4), R48
- https://doi.org/10.1186/bcr2605
Abstract
B7-H1 (PD-L1, CD274) is a T cell inhibitory molecule expressed in many types of cancer, leading to immune escape of tumor cells. Indeed, in previous reports we have shown an association of B7-H1 expression with high-risk breast cancer patients.Keywords
This publication has 50 references indexed in Scilit:
- In search of nonribosomal nucleolar protein function and regulationThe Journal of cell biology, 2009
- Immunogenicity of anthracyclines: moving towards more personalized medicineTrends in Molecular Medicine, 2008
- B7-H1 is a ubiquitous antiapoptotic receptor on cancer cellsBlood, 2008
- Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapyNature Medicine, 2007
- The p16INK4a tumor suppressor controls p21WAF1 induction in response to ultraviolet lightNucleic Acids Research, 2006
- Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trialsThe Lancet, 2005
- Phosphorylation and Regulation of Akt/PKB by the Rictor-mTOR ComplexScience, 2005
- Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and CardiotoxicityPublished by American Society for Pharmacology & Experimental Therapeutics (ASPET) ,2004
- Specificity and mechanism of action of some commonly used protein kinase inhibitorsBiochemical Journal, 2000
- A critical evaluation of the mechanisms of action proposed for the antitumor effects of the anthracycline antibiotics adriamycin and daunorubicinBiochemical Pharmacology, 1999